Cardinal Health (CAH) Stock
Key stats
- Market cap
- $62.02B
- Price / Earnings ratio
- 35.5x
- EPS (TTM)
- $7.27
- Volume
- Loading
- 52-week high
- $262.29
- 52-week low
- $180.45
- Dividend yield
- 0.77%
- Dividend amount (latest)
- $0.51
- EPS vs analyst estimate
- +16.4%Q1 FY26 · $2.55 vs $2.19
Source: third-party data provider, as of November 7, 2026
EPS estimate: analyst consensus
Compare with CAH
Recent news

CAH Shares Post New Record, EW Stock Hits Over Three-Year High – What’s Driving Today’s Rally?
CAH Shares Post New Record, EW Stock Hits Over Three-Year High – What’s Driving Today’s Rally?
CAH

What Analyst Projections for Key Metrics Reveal About Cardinal (CAH) Q1 Earnings
What Analyst Projections for Key Metrics Reveal About Cardinal (CAH) Q1 Earnings
CAH

Can CAH's Specialty Strength Offset Medical Distribution Challenges in Q1?
Can CAH's Specialty Strength Offset Medical Distribution Challenges in Q1?
CAH

Cardinal Health (CAH) Stock Slides as Market Rises: Facts to Know Before You Trade
Cardinal Health (CAH) Stock Slides as Market Rises: Facts to Know Before You Trade
CAH
News tone: automated (AI) classification of the article's content, not a price prediction.
Technical indicators
- RSI 14
- 71.62
- MACD 12/26/9
- 6.05
- EMA 9 of MACD
- 5.12
- MACD histogram
- 0.93
- SMA 50
- $239.75
- Price above SMA 50
- EMA 50
- $242.45
- Price above EMA 50
- SMA 200
- $223.12
- Price above SMA 200
- EMA 200
- $224.90
- Price above EMA 200
Calculated by Gotrade from daily closing prices, as of November 5, 2026. Technical data, not a recommendation.
Analyst ratings
Analyst consensus: Buy
Based on 11 analyst ratings
Third-party analyst opinion, not a recommendation from Gotrade.
Financials
Performance
Debt & Balance Sheet
Revenue to Profit
2026Earnings
The market is expecting earnings per share of $2.60 for this quarter. The company has not yet shared when it is announcing earnings.
Source: third-party data provider
Latest news

CAH Shares Post New Record, EW Stock Hits Over Three-Year High – What’s Driving Today’s Rally?
CAH Shares Post New Record, EW Stock Hits Over Three-Year High – What’s Driving Today’s Rally?
CAH

What Analyst Projections for Key Metrics Reveal About Cardinal (CAH) Q1 Earnings
What Analyst Projections for Key Metrics Reveal About Cardinal (CAH) Q1 Earnings
CAH

Can CAH's Specialty Strength Offset Medical Distribution Challenges in Q1?
Can CAH's Specialty Strength Offset Medical Distribution Challenges in Q1?
CAH

Cardinal Health (CAH) Stock Slides as Market Rises: Facts to Know Before You Trade
Cardinal Health (CAH) Stock Slides as Market Rises: Facts to Know Before You Trade
CAH

Cardinal Health (CAH) Laps the Stock Market: Here's Why
Cardinal Health (CAH) Laps the Stock Market: Here's Why
CAH

Cardinal Health (CAH) Laps the Stock Market: Here's Why
Cardinal Health (CAH) Laps the Stock Market: Here's Why
CAH

3 Low-Beta Defensive Stocks to Buy as Inflation Continues to Surge
3 Low-Beta Defensive Stocks to Buy as Inflation Continues to Surge
CAH

Here's Why Cardinal Health (CAH) is a Strong Growth Stock
Here's Why Cardinal Health (CAH) is a Strong Growth Stock
CAH

Should Value Investors Buy Cardinal Health (CAH) Stock?
Should Value Investors Buy Cardinal Health (CAH) Stock?
CAH

Are Medical Stocks Lagging Cardinal Health (CAH) This Year?
Are Medical Stocks Lagging Cardinal Health (CAH) This Year?
CAH
News tone: automated (AI) classification of the article's content, not a price prediction.
About Cardinal Health
Headquartered in Dublin, Ohio, Cardinal Health, Inc. is a global, integrated healthcare services and products company, providing customized solutions for hospitals, health systems, pharmacies, ambulatory surgery centers, clinical laboratories and physician offices worldwide.
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Mr. Jason M. Hollar | CEO & Director | 1973 |
| Mr. Stephen M. Mason | Chief Executive Officer of GMPD segment | 1971 |
| Ms. Deborah L. Weitzman | Chief Executive Officer of Pharmaceutical & Specialty Solutions Segment | 1965 |
| Mr. Aaron E. Alt J.D. | Chief Financial Officer | 1972 |
| Ms. Jessica L. Mayer | Chief Legal & Compliance Officer | 1969 |
| Ms. Mary C. Scherer | Senior VP & Chief Accounting Officer | — |
| Mr. David Frost | Vice President of Investor Relations | — |
| Ms. Valerie Christine Pitteroff | Chief Human Resources Officer | 1971 |
| Mr. Craig Cowman | President of Biopharma Solutions & Strategic Sourcing | — |
| Mr. Ben Brinker | President of Global Operations & Supply Chain | — |
Fundamentals
Valuation
Profitability
Trading
Dividend
Source: third-party data provider, as of November 7, 2026
Technical indicators
- RSI 14
- 71.62
- MACD 12/26/9
- 6.05
- EMA 9 of MACD
- 5.12
- MACD histogram
- 0.93
- SMA 50
- $239.75
- Price above SMA 50
- EMA 50
- $242.45
- Price above EMA 50
- SMA 200
- $223.12
- Price above SMA 200
- EMA 200
- $224.90
- Price above EMA 200
Calculated by Gotrade from daily closing prices, as of November 5, 2026. Technical data, not a recommendation.
Analyst views
11 analyst ratings
Third-party analyst opinion, not a recommendation from Gotrade.
- Low
- $260.00
- Average
- $277.55
- High
- $295.00
Seasonality
Monthly price change (%)| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021 | -6.9 | +12.3 | ||||||||||
| 2022 | -0.8 | +5.2 | +7.3 | +0.8 | -3.0 | -5.7 | +12.2 | +17.2 | -6.5 | +11.7 | +6.3 | -3.0 |
| 2023 | +0.7 | -0.0 | -0.6 | +7.0 | +0.1 | +13.4 | -3.3 | -4.7 | -0.9 | +5.3 | +14.4 | -5.9 |
| 2024 | +6.4 | +6.5 | -1.3 | -8.0 | -2.8 | -1.2 | +3.1 | +9.0 | -3.6 | -1.6 | +5.3 | -3.4 |
| 2025 | +4.8 | +3.3 | +6.6 | +3.0 | +6.1 | +8.2 | -5.6 | -4.6 | +5.0 | +20.8 | +11.6 | -1.2 |
| 2026 | +4.5 | +4.7 | -8.1 | -9.0 | +0.8 | +21.7 | -3.2 | -0.4 | -7.0 | +8.9 | +5.3 |
Corporate actions
Upcoming
No upcoming corporate actions for CAH



